栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/10/05 | 2,229 | 2,289 | 2,229 | 2,270 | +54 | +2.4% | 428,800 |
2020/10/02 | 2,236 | 2,260 | 2,202 | 2,216 | - | - | 579,300 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 2,152 | 2,170 | 2,114 | 2,116 | -33 | -1.5% | 211,800 |
2020/09/29 | 2,104 | 2,153 | 2,084 | 2,149 | +10 | +0.5% | 193,000 |
2020/09/28 | 2,134 | 2,152 | 2,114 | 2,139 | +34 | +1.6% | 220,600 |
2020/09/25 | 2,120 | 2,159 | 2,102 | 2,105 | -11 | -0.5% | 190,700 |
2020/09/24 | 2,103 | 2,146 | 2,100 | 2,116 | +4 | +0.2% | 269,800 |
2020/09/23 | 2,124 | 2,143 | 2,112 | 2,112 | -19 | -0.9% | 170,200 |
2020/09/18 | 2,122 | 2,140 | 2,111 | 2,131 | +13 | +0.6% | 273,600 |
2020/09/17 | 2,068 | 2,123 | 2,056 | 2,118 | +57 | +2.8% | 415,500 |
2020/09/16 | 2,036 | 2,072 | 2,036 | 2,061 | +40 | +2% | 209,600 |
2020/09/15 | 2,050 | 2,058 | 2,014 | 2,021 | -33 | -1.6% | 238,300 |
2020/09/14 | 2,035 | 2,054 | 2,031 | 2,054 | +8 | +0.4% | 161,900 |
2020/09/11 | 2,005 | 2,047 | 1,987 | 2,046 | +55 | +2.8% | 320,300 |
2020/09/10 | 1,983 | 2,007 | 1,977 | 1,991 | +11 | +0.6% | 169,400 |
2020/09/09 | 1,968 | 1,987 | 1,949 | 1,980 | -17 | -0.9% | 197,700 |
2020/09/08 | 1,964 | 1,998 | 1,951 | 1,997 | +40 | +2% | 230,200 |
2020/09/07 | 1,927 | 1,976 | 1,918 | 1,957 | +26 | +1.3% | 179,400 |
2020/09/04 | 1,930 | 1,946 | 1,914 | 1,931 | -29 | -1.5% | 142,700 |
2020/09/03 | 1,950 | 1,960 | 1,934 | 1,960 | +12 | +0.6% | 236,600 |
2020/09/02 | 1,925 | 1,948 | 1,924 | 1,948 | +25 | +1.3% | 224,600 |
2020/09/01 | 1,920 | 1,923 | 1,886 | 1,923 | +16 | +0.8% | 153,500 |
2020/08/31 | 1,879 | 1,915 | 1,868 | 1,907 | +28 | +1.5% | 161,800 |
2020/08/28 | 1,888 | 1,930 | 1,851 | 1,879 | -9 | -0.5% | 263,500 |
2020/08/27 | 1,891 | 1,903 | 1,875 | 1,888 | -33 | -1.7% | 198,500 |
2020/08/26 | 1,897 | 1,937 | 1,887 | 1,921 | +32 | +1.7% | 398,800 |
2020/08/25 | 1,907 | 1,907 | 1,880 | 1,889 | -43 | -2.2% | 207,100 |
2020/08/24 | 1,889 | 1,932 | 1,879 | 1,932 | +49 | +2.6% | 294,000 |
2020/08/21 | 1,880 | 1,899 | 1,880 | 1,883 | +21 | +1.1% | 119,700 |
2020/08/20 | 1,861 | 1,879 | 1,855 | 1,862 | -21 | -1.1% | 140,600 |
2020/08/19 | 1,899 | 1,906 | 1,871 | 1,883 | -16 | -0.8% | 113,800 |
2020/08/18 | 1,880 | 1,914 | 1,873 | 1,899 | +12 | +0.6% | 301,000 |
2020/08/17 | 1,862 | 1,888 | 1,861 | 1,887 | +18 | +1% | 171,300 |
2020/08/14 | 1,874 | 1,893 | 1,860 | 1,869 | +7 | +0.4% | 205,300 |
2020/08/13 | 1,860 | 1,881 | 1,852 | 1,862 | +20 | +1.1% | 239,300 |
2020/08/12 | 1,818 | 1,848 | 1,792 | 1,842 | +13 | +0.7% | 213,100 |
2020/08/11 | 1,801 | 1,836 | 1,801 | 1,829 | +34 | +1.9% | 262,000 |
2020/08/07 | 1,802 | 1,819 | 1,790 | 1,795 | -16 | -0.9% | 210,700 |
2020/08/06 | 1,851 | 1,858 | 1,811 | 1,811 | -55 | -2.9% | 188,900 |
2020/08/05 | 1,806 | 1,869 | 1,799 | 1,866 | +60 | +3.3% | 377,200 |
2020/08/04 | 1,886 | 1,895 | 1,796 | 1,806 | -66 | -3.5% | 453,900 |
2020/08/03 | 1,883 | 1,886 | 1,812 | 1,872 | -3 | -0.2% | 420,500 |
2020/07/31 | 1,866 | 1,944 | 1,864 | 1,875 | +33 | +1.8% | 932,100 |
2020/07/30 | 1,819 | 1,855 | 1,814 | 1,842 | +32 | +1.8% | 582,700 |
2020/07/29 | 1,760 | 1,813 | 1,739 | 1,810 | +49 | +2.8% | 719,000 |
2020/07/28 | 1,717 | 1,781 | 1,702 | 1,761 | +84 | +5% | 897,800 |
2020/07/27 | 1,655 | 1,679 | 1,628 | 1,677 | -2 | -0.1% | 403,200 |
2020/07/22 | 1,668 | 1,680 | 1,653 | 1,679 | +4 | +0.2% | 289,400 |
2020/07/21 | 1,640 | 1,675 | 1,638 | 1,675 | +35 | +2.1% | 260,800 |
1001~
1050
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 30.69倍 | 1.75倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム